Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marin Nola

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Diagnostic Cytopathology|September 18, 2009
CD13+ anaplastic large cell lymphoma with leukemic presentation and additional chromosomal abnormalitySuncica Ries, Lana Rnjak, Zdravko Mitrović, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 1, 2008
Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infectionMirela M Dabić, Marin Nola, Ivana Tomicić, et al.
Tumori|April 16, 2009
Treatment of multiple relapsing non-melanoma skin cancers in a patient with severe hemophilia ASilva Zupancic Salek, Ivo Radman, Drazen Pulanic, et al.
Lijecnicki Vjesnik|August 19, 2007
[Leukocytoclastic vasculitis in primary Sjögren syndrome: a case report]Nadica Laktasić-Zerjavić, Branimir Anić, Bozidar Curković, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndromeMiroslav Dumic, Ivo Radman, Nevena Krnic, et al.
International Journal of Hematology|June 5, 2009
Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximabIvana Ilić, Zdravko Mitrović, Igor Aurer, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphomaZdravko Mitrovic, Ivana Ilic, Marin Nola, et al.
American Journal of Hematology|August 13, 2004
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphomaMarin Nola, Steven Z Pavletic, Dennis D Weisenburger, et al.
Lijecnicki Vjesnik|August 9, 2005
[Rituximab in the treatment of indolent non-Hodgkin's lymphoma]Igor Aurer, Zdravko Mitrović, Ivo Radman, et al.
Lijecnicki Vjesnik|June 15, 2007
[Treatment of hairy cell leukemia with cladribine]Igor Aurer, Zdravko Mitrović, Jasminka Kovacević-Metelko, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Diagnostic Cytopathology|September 18, 2009
CD13+ anaplastic large cell lymphoma with leukemic presentation and additional chromosomal abnormalitySuncica Ries, Lana Rnjak, Zdravko Mitrović, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 1, 2008
Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infectionMirela M Dabić, Marin Nola, Ivana Tomicić, et al.
Tumori|April 16, 2009
Treatment of multiple relapsing non-melanoma skin cancers in a patient with severe hemophilia ASilva Zupancic Salek, Ivo Radman, Drazen Pulanic, et al.
Lijecnicki Vjesnik|August 19, 2007
[Leukocytoclastic vasculitis in primary Sjögren syndrome: a case report]Nadica Laktasić-Zerjavić, Branimir Anić, Bozidar Curković, et al.
Clinical Lymphoma & Myeloma|January 12, 2008
Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndromeMiroslav Dumic, Ivo Radman, Nevena Krnic, et al.
International Journal of Hematology|June 5, 2009
Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximabIvana Ilić, Zdravko Mitrović, Igor Aurer, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphomaZdravko Mitrovic, Ivana Ilic, Marin Nola, et al.
American Journal of Hematology|August 13, 2004
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphomaMarin Nola, Steven Z Pavletic, Dennis D Weisenburger, et al.
Lijecnicki Vjesnik|August 9, 2005
[Rituximab in the treatment of indolent non-Hodgkin's lymphoma]Igor Aurer, Zdravko Mitrović, Ivo Radman, et al.
Lijecnicki Vjesnik|June 15, 2007
[Treatment of hairy cell leukemia with cladribine]Igor Aurer, Zdravko Mitrović, Jasminka Kovacević-Metelko, et al.
Pageof 2